• linkedin
  • Increase Font
  • Sharebar

    The pain-med choke point

    Steve AriensSteve AriensIn December, NCPA sent out a survey asking pharmacists whether they are having increasing difficulty acquiring controlled medications. While the survey was still open (it closed December 18, 2013), NCPA released some early comments.

    It prefaced them with a statement that said in part, “For some time NCPA has been aware and working to resolve the issue of an increasing number of pharmacies being unable to procure controlled substances to fill prescriptions. This, of course, is a great concern not only for our members but for patients who need these medications most often to treat acute or chronic pain. To better understand the prevalence of this situation and its impact on patient access, NCPA’s most recent action was to send a member survey you should have received.”

    Steven R. Ariens, PD
    Steve Ariens is a pharmacy advocate, blogger, and National Public Relations Director for The Pharmacy Alliance ...


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • KimLawson
      This is bad medicine.The Xanax or hydrocodone Pts.can be turned away because of limits? Do they not go elsewhere if pharmacy has reached their allotted Amt.
    • Anonymous
      Am I the only one who thinks it a bit ironic that the DEA, who sets annual production quotas of opiate products with manufacturers, is now setting a de facto quota system for how much can be dispensed? And the two numbers don't seem to match.